Greater Durability and Protection against Herpes Simplex Viral Disease following Immunization of Mice with Single-Cycle ΔgD-2 Compared to an Adjuvanted Glycoprotein D Protein Vaccine
Herpes simplex viruses (HSV) cause chronic infections with significant morbidity. Prior vaccines, designed to generate neutralizing antibodies (nAbs) targeting glycoprotein D (gD), failed to provide durable protection. We adopted a different strategy and evaluated a single-cycle virus deleted in gD...
Main Authors: | Aakash Mahant Mahant, Matthew S. Gromisch, Leah Kravets, Clare Burn Aschner, Betsy C. Herold |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/8/1362 |
Similar Items
-
Antibodies Elicited in Response to a Single Cycle Glycoprotein D Deletion Viral Vaccine Candidate Bind C1q and Activate Complement Mediated Neutralization and Cytolysis
by: Maria Luisa Visciano, et al.
Published: (2021-06-01) -
A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
by: Masayuki Kuraoka, et al.
Published: (2023-02-01) -
Developments in Vaccination for Herpes Simplex Virus
by: Rohini Krishnan, et al.
Published: (2021-12-01) -
Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection
by: Karin Önnheim, et al.
Published: (2016-04-01) -
Anti-Glycoprotein G Antibodies of Herpes Simplex Virus 2 Contribute to Complete Protection after Vaccination in Mice and Induce Antibody-Dependent Cellular Cytotoxicity and Complement-Mediated Cytolysis
by: Staffan Görander, et al.
Published: (2014-11-01)